The 50 references in paper N. Kuzubova A., E. Lebedeva S., O. Titova N., Н. Кузубова А., Е. Лебедева С., О. Титова Н. (2016) “Полимодальные эффекты тиотропия бромида в терапии хронической обструктивной болезни легких // Multiple effects of tiotropium in chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2015:i:5:p:613-621

1
Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Update 2014. www.goldcopd.com
(check this in PDF content)
2
Wessler I., Kirkpatrick C.J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 2008; 154 (8): 1558–1571.
(check this in PDF content)
3
Gosens R., Zaagsma J., Meurs H., Halayko A. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir. Res.2006; 7: 73.
(check this in PDF content)
4
Alagha K., Palot A., Sofalvi T. et al. Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. Ther. Adv. Chronic. Dis. 2014; 5 (2): 85–98. Таблица Полимодальные эффекты тиотропия бромида Table Multiple effects of tiotropium bromide ЭффектыМеханизм действияТерапевтический эффект Нейрональные БронходилатацияБлокада М8холинорецепторов перибронхиальных Улучшение легочной функции, уменьшение парасимпатических ганглиевгиперинфляции легких и одышки, повышение толерантности к физической нагрузке, улучшение качества жизни Блокада деполяризации сенсорных волокон и входа ионов кальция через взаимодействие с ванилоидными рецепторами С8волокон дыхательных путей Ненейрональные ПротивовоспалительныйСнижение продукции провоспалительных цитокинов Уменьшение локального
(check this in PDF content)
5
Ikeda T., Anisuzzaman A.S.M., Yoshiki H. et al. Regional quantification of muscarinic acetylcholine receptors and b-adrenoceptors in human airways. Br. J. Pharmacol.2012; 166: 1804–1814.
(check this in PDF content)
6
Bateman E.D., Rennard S., Barnes P.J. et al. Alternative mechanisms for tiotropium. Pulm. Pharmacol. Ther.2009; 22 (6): 533–542.
(check this in PDF content)
7
Celli B., ZuWallack R., Wang S., Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003; 124 (5): 1743–1748.
(check this in PDF content)
8
O’Donnell D.E., Fluge T., Gerken F. et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur. Resp. J. 2004; 23 (6): 832–840.
(check this in PDF content)
9
Buels K.S., Fryer A.D. Muscarinic receptor antagonists: effects on pulmonary function. Handb. Exp. Pharmacol. 2012; 208: 317–341.
(check this in PDF content)
10
Tashkin D.P., Celli B., Senn S. et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N. Engl. J. Med.2008; 359 (15): 1543–1554.
(check this in PDF content)
11
Celli B., Decramer M., Leimer I. et al. Cardiovascular safety of tiotropium in patients with COPD. Chest. 2010; 137 (1): 20–30.
(check this in PDF content)
12
Авдеев С.Н. Вопросы сердечно-сосудистой безопасности длительной терапии тиотропием пациентов с ХОБЛ. Consilium Medicum.2012; 14 (3): 34–39. / Avdeev S.N. Issued of cardiovascular safety of long-term therapy with tiotropium in COPD patients. Consilium Medicum.2012; 14 (3): 34–39 (in Russian).
(check this in PDF content)
13
Barnes P.J. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin. Chest Med. 2014; 35 (1): 71–86.
(check this in PDF content)
14
Wise R.A., Anzueto A., Cotton D. et al. Tiotropium Respimat inhaler and the risk of death in COPD. N. Engl. J. Med. 2013; 369 (16): 1491–501.
(check this in PDF content)
15
Karakiulakis G., Roth M. Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects.Mediators Inflamm.2012; 2012: 409580.
(check this in PDF content)
16
Pieper M.P. The non-neuronal cholinergic system as novel drug target in the airways. Life Sci. 2012; 91 (21–22): 1113–1118.
(check this in PDF content)
17
Meurs H., Dekkers B.G., Maarsingh H. et al. Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Pulm. Pharmacol. Ther. 2013; 26 (1): 145–155.
(check this in PDF content)
18
Koarai A., Traves S.L., Fenwick P.S. et al. Expression of muscarinic receptors by human macrophages.Eur. Respir. J. 2012; 39 (3): 698–704.
(check this in PDF content)
19
Moffatt J.D., Cocks T.M., Page C.P. Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br. J. Pharmacol.
(check this in PDF content)
20
4; 141 (7): 1159–1166. 20. Kistemaker L.E., Oenema T.A., Meurs H., Gosens R. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Life Sci. 2012; 91 (21–22): 1126–1133.
(check this in PDF content)
21
Xu Z.P., Devillier P., Xu G.N. et al. TNF-α-induced CXCL8 production by A549 cells: involvement of the non-neuronal cholinergic system. Pharmacol. Res.2013; 68 (1): 16–23.
(check this in PDF content)
22
Profita M., Giorgi R.D., Sala A. et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy. 2005; 60: 1361–1369.
(check this in PDF content)
23
Елшин Н.Д., Чухловин А.Б., Кузубова Н.А., Титова О.Н. Определение экспрессии генов CHRM3 и ADRB2 в лейкоцитах крови в процессе комплексного лечения хронической обструктивной болезни легких. / Мультидисциплинарные аспекты молекулярной медицины. СПб: Издательство Санкт'Петербургского государственного экономического университета;2015: 71–72. / Elshin N.D., Chukhlovin A.B., Kuzubova N.A., Titova O.N. CHRM3 and ADRB2 gene expression in blood leukocytes during treatment of chronic obstructive pulmonary disease. / Multidisciplinary aspects of molecular medicine. Saint-Petersburg: Izdatel'stvo Sankt'Peterburgskogo gosudarstvennogo ekonomicheskogo uni' versiteta; 2015: 71–72 (in Russian).
(check this in PDF content)
24
Zhang L., Cheng Z., Liu W., Wu K. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD. 2013; 10 (4): 459–465.
(check this in PDF content)
25
Profita M., Albano G.D., Riccobono L. et al. Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients. Immunobiology. 2014; 219 (5): 392–401.
(check this in PDF content)
26
Xu Z.P., Song Y., Yang K. et al. M3 mAChR-mediated IL-8 expression through PKC/NF-κB signaling pathways. Inflamm. Res.2014; 63 (6): 463–473.
(check this in PDF content)
27
Kolahian S., Shahbazfar A.A., Tayefi-Nasrabadi H. et al. Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation. Exp. Lung Res. 2014; 40 (6): 272–287.
(check this in PDF content)
28
Bühling F., Lieder N., Kühlmann U.C. et al. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir. Med. 2007; 101 (11): 2386–2394.
(check this in PDF content)
29
Vacca G., Randerath W.J., Gillissen A. Inhibition of granulocyte migration by tiotropium bromide. Respir. Res.2011; 12 (1): 24–29.
(check this in PDF content)
30
Santus P., Buccellati C., Centanni S. et al. Bronchodilators modulate inflammation in chronic obstructive pulmonary disease subjects. Pharmacol. Res.2012; 66 (4): 343–348.
(check this in PDF content)
31
Yamaya M., Nishimura H., Hatachi Y. et al. Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells. Eur. Respir. J.2012; 40 (1): 122–132.
(check this in PDF content)
32
Koppen C.J., Kaiser B. Regulation of muscarinic acetylcholine receptor signaling. Pharmacol. Ther. 2003; 98 (2): 197–220.
(check this in PDF content)
33
Oenema T.A., Kolahian S., Nanninga J.E. et al. Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir. Res.2010; 11: article 130.
(check this in PDF content)
34
Suzaki I., Asano K., Shikama Y. et al. Suppression of IL-8 production from airway cells by tiotropium bromide in vitro. Int. J. Chron. Obstruct. Pulm. Dis.2011; 6: 439–448.
(check this in PDF content)
35
Profita M., Bonanno A., Montalbano A.M. et al. Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sci. 2011; 89 (1–2): 36–43.
(check this in PDF content)
36
Profita M., Albano G.D., Montalbano A.M. et al. Acetylcholine leads to signal transducer and activator of transcription 1 (STAT-1) mediated oxidative / nitrosative stress in human bronchial epithelial cell line. Biochim. Biophys. Acta.2013; 1832 (12): 1949–1958.
(check this in PDF content)
37
Holownia A., Mroz R.M., Wielgat P. et al. Altered histone deacetylase activity and iNOS expression in cells isolated from induced sputum of COPD patients treated with tiotropium.Adv. Exp. Med.Biol. 2013; 788: 1–6.
(check this in PDF content)
38
Holownia A., Mroz R.M., Skopinski T. et al. Tiotropium increases PPAR? and decreases CREB in cells isolated from induced sputum of COPD patients. Adv. Exp. Med. Biol. 2013; 756: 9–14.
(check this in PDF content)
39
Kistemarker L.E., Gosens R. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling. Trends Pharmacol. Sci. 2015; 36 (3): 164–171.
(check this in PDF content)
40
Pera T., Zuidhof A., Valadas J. et al. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD.Eur. Respir. J. 2011; 38 (4): 789–796.
(check this in PDF content)
41
Arai N., Kondo M., Izumo T. et al. Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur. Respir. J. 2010; 35 (5): 1164–1171.
(check this in PDF content)
42
Gosens R., Bos I.S., Zaagsma J., Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am. J. Respir. Crit. Care Med. 2005; 171 (10): 1096–1102.
(check this in PDF content)
43
Asano K., Shikama Y., Shoji N. et al. Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro. Int. J. Chron. Obsrtruct. Pulm. Dis.2010; 5: 277–286.
(check this in PDF content)
44
Кузубова Н.А., Федин А.Н., Лебедева Е.С., Платонова И.С. Влияние различных вариантов терапии на сокращение бронхов крыс с моделированной обструктивной болезнью легких. Российский физиологический журнал им. И.М.Сеченова. 2014; 100 (9): 1049–1058. / Kuzubova N.A., Fedin A.N., Lebedeva E.S., Platonova I.S. Effects of different treatments on bronchial constriction in rat models of obstructive lung disease. Rossiyskiy fiziologicheskiy zhurnal im. I.M.Sechenova. 2014; 100 (9): 1049– 1058 (in Russian).
(check this in PDF content)
45
Birrell M.A., Bonvini S.J., Dubuis E. et al. Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: A beneficial off-target effect? J. Allergy Clin. Immunol. 2014; 133 (3): 679–687.e9.
(check this in PDF content)
46
Laube B.L., Janssens H.M., de Jongh F.H. et al. What the pulmonary specialist should know about the new inhalation therapies. Eur. Respir. J. 2011; 37 (6): 1308–1331.
(check this in PDF content)
47
Malmberg L.P., RytiläP., Happonen P., Haahtela T. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters. Int. J. Chron. Obstruct. Pulm. Dis.2010; 5: 257–262.
(check this in PDF content)
48
Архипов В.В., Абросимов А.Г., Архипова Д.Е. Спирива Респимат – новое направление в лечении ХОБЛ. Рус' ский медицинский журнал. 2013; 7: 379–383. / Arkhipov V.V., Abrosimov A.G., Arkhipova D.E. Spiriva Respimat is a novel approach to therapy of COPD. Russkiy meditsinskiy zhurnal. 2013; 7: 379–383 (in Russian).
(check this in PDF content)
49
Barczok M., Perleberg C., Kardos P., Hodder R. Presented at VIII Deutsches Aerosol Therapie Seminar, Marburg, Germany, November 2003. http://experts.respimat.com/ presentation_kit/patient_preference.html
(check this in PDF content)
50
Noord J.A., Cornelissen P.J., Aumann J.L. et al. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. Respir. Med. 2009; 103 (1): 22–29. Поступила 02.11.15
(check this in PDF content)